A targeted RNA therapy boosts VEGF‑A in transplanted beta cells, accelerating blood-vessel growth and improving islet survival and glucose control for Type 1 diabetes.

New antibodies recognize mutant KRAS fragments displayed on tumor cells, unlocking a way to target pancreatic, colorectal, and lung cancers.

Trump signed an executive order to reshape the childhood vaccine schedule. He made multiple false claims, including repeating the debunked vaccines and autism link.

Two undisclosed deaths in Chinese gene-editing trials renew concerns about trial oversight, safety reporting, and transparency as gene therapy advances worldwide.

Two undisclosed deaths in Chinese gene-editing trials renew concerns about trial oversight, safety reporting, and transparency as gene therapy advances worldwide.

Hospitals often earn large spreads on high-volume branded drugs bought via 340B. Reforms may make hospitals more price-sensitive, raisin uptake of lower-cost biosimilars.

Proposed bills could directly lead to lowering patient out-of-pocket costs for items like insulin. Others may indirectly impact costs by curbing possible patent abuses,

Setidegrasib, a first-in-class KRAS G12D degrader, uses the cell’s own recycling system to destroy a key cancer driver instead of merely blocking it.

Large reviews show that one to three cups of brewed coffee a day are linked with lower risks of liver disease, heart disease, stroke and Type 2 diabetes in most adults.

The abortion pill mifepristone remains embroiled in U.S. legal, political and regulatory battles, despite the Supreme Court temporarily restoring mail access.